Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults

References

• Griffin MR, Walker FJ, Iwane MK, Weinberg GA, Staat MA, Erdman DD. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr Infect Dis J. 2004;23:S188–92. doi:10.1097/01.inf.0000144660.53024.64.
   PubMedGoogle Scholar
• Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–55. doi:10.1016/S0140-6736(10)60206-1.
   PubMed Web of Science ®Google Scholar
• Shi T, McLean K, Campbell H, Nair H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta–analysis. J Glob Health. 2015;5:010408.
   Web of Science ®Google Scholar
• Couch RB, Englund JA. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med. 1997;102:2–9. doi:10.1016/S0002-9343(97)00003-X.
   PubMedGoogle Scholar
• Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588–98. doi:10.1056/NEJMoa0804877.
   PubMed Web of Science ®Google Scholar
• Counihan ME, Shay DK, Holman RC, Lowther SA, Anderson LJ. Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J. 2001;20:646–53. doi:10.1097/00006454-200107000-00003.
   PubMed Web of Science ®Google Scholar
• Steffens A, Finelli L, Whitaker B, Fowlkes A. Population-based surveillance for medically attended human parainfluenza viruses from the influenza incidence surveillance project, 2010-2014. Pediatr Infect Dis J. 2016;35:717–22. doi:10.1097/INF.0000000000001140.
   PubMed Web of Science ®Google Scholar
• Weinberg GA, Hall CB, Iwane MK, Poehling KA, Edwards KM, Griffin MR, Staat MA, Curns AT, Erdman DD, Szilagyi PG, et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr. 2009;154:694–99. doi:10.1016/j.jpeds.2008.11.034.
   PubMed Web of Science ®Google Scholar
• Schmidt AC, Schaap-Nutt A, Bartlett EJ, Schomacker H, Boonyaratanakornkit J, Karron RA, Collins PL. Progress in the development of human parainfluenza virus vaccines. Expert Rev Respir Med. 2011;5(4):515–26. doi:10.1586/ers.11.32.
   PubMed Web of Science ®Google Scholar
• Rossey I, Saelens X. Vaccines against human respiratory syncytial virus in clinical trials, where are we now? Expert Rev Vaccines. 2019;18(10):1053–67. doi:10.1080/14760584.2019.1675520.
   PubMed Web of Science ®Google Scholar
• Hurwitz JL. Development of recombinant Sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infections. Pediatr Infect Dis J. 2008;27(Supplement):S126–8. doi:10.1097/INF.0b013e318168b780.
   PubMedGoogle Scholar
• Slobod KS, Shenep JL, Lujan-Zilbermann J, Allison K, Brown B, Scroggs RA, Portner A, Coleclough C, Hurwitz JL. Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults. Vaccine. 2004;22(23–24):3182–86. doi:10.1016/j.vaccine.2004.01.053.
   PubMed Web of Science ®Google Scholar
• Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, Freiden P, Slobod KS, Gaur AH, Hayden RT, et al. Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children. Clin Vaccine Immunol. 2015;22(3):298–303. doi:10.1128/CVI.00618-14.
   PubMedGoogle Scholar
• Zhan X, Hurwitz JL, Krishnamurthy S, Takimoto T, Boyd K, Scroggs RA, Surman S, Portner A, Slobod KS. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Vaccine. 2007;25(52):8782–93. doi:10.1016/j.vaccine.2007.10.038.
   PubMed Web of Science ®Google Scholar
• Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, Surman S, Russell CJ, Portner A, Hurwitz JL, et al. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats. Int Immunol. 2015;27(5):229–36. doi:10.1093/intimm/dxu107.
   PubMed Web of Science ®Google Scholar
• Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL. Sendai virus-based RSV vaccine protects African green monkeys from RSV infection. Vaccine. 2012;30(5):959–68. doi:10.1016/j.vaccine.2011.11.046.
   PubMed Web of Science ®Google Scholar
• Jones BG, Sealy RE, Surman SL, Portner A, Russell CJ, Slobod KS, Dormitzer PR, DeVincenzo J, Hurwitz JL. Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model. Vaccine. 2014;32(26):3264–73. doi:10.1016/j.vaccine.2014.03.088.
   PubMed Web of Science ®Google Scholar
• Russell CJ, Jones BG, Sealy RE, Surman SL, Mason JN, Hayden RT, Tripp RA, Takimoto T, Hurwitz JL. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge. Virology. 2017;509:60–66. doi:10.1016/j.virol.2017.05.021.
   PubMed Web of Science ®Google Scholar
• Hurwitz JL, Soike KF, Sangster MY, Portner A, Sealy RE, Dawson DH, Coleclough C. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine. 1997;15(5):533–40. doi:10.1016/S0264-410X(97)00217-X.
   PubMed Web of Science ®Google Scholar
• Surman SL, Rudraraju R, Sealy R, Jones B, Hurwitz JL. Vitamin A deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract. Viral Immunol. 2012;25:341–44. doi:10.1089/vim.2012.0023.
   PubMed Web of Science ®Google Scholar
• Ishii H, Matano T. Development of an AIDS vaccine using Sendai virus vectors. Vaccine. 2015;33:6061–65. doi:10.1016/j.vaccine.2015.06.114.
   PubMed Web of Science ®Google Scholar
• Lamb RA and Griffith DP. Paramyxoviridae: The viruses and their replication. In: Fields Virology. Editors: Knipe DM and Howley PM, Philadelphia, PA: Lippincott Williams & Wilkins; 2007:1449-96.
   Google Scholar